These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25612180)

  • 1. HIV prevention: integrating biomedical and behevioral interventions.
    Del Rio C
    Top Antivir Med; 2014 Dec-2015 Jan; 22(5):702-6. PubMed ID: 25612180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.
    Volberding PA
    Top Antivir Med; 2017; 25(1):17-24. PubMed ID: 28402930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.
    Marrazzo JM; del Rio C; Holtgrave DR; Cohen MS; Kalichman SC; Mayer KH; Montaner JS; Wheeler DP; Grant RM; Grinsztejn B; Kumarasamy N; Shoptaw S; Walensky RP; Dabis F; Sugarman J; Benson CA;
    JAMA; 2014 Jul 23-30; 312(4):390-409. PubMed ID: 25038358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation.
    Landovitz RJ
    Top Antivir Med; 2015; 23(2):85-90. PubMed ID: 26200708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care continuum entry interventions: seek and test strategies to engage persons most impacted by HIV within the United States.
    McNulty MC; Schneider JA
    AIDS; 2018 Feb; 32(4):407-417. PubMed ID: 29381558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Infection in Hard-to-Reach Populations.
    Del Rio C
    Top Antivir Med; 2016; 24(2):86-89. PubMed ID: 27841977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    Huang YA; Tao G; Samandari T; Hoover KW
    J Infect Dis; 2018 Jan; 217(4):617-621. PubMed ID: 29145597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Can We Learn From Measles? No New HIV Infections.
    Smith DM
    Top Antivir Med; 2015; 23(3):108-10. PubMed ID: 26518393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Horvath T; Rutherford G
    JAMA; 2013 Oct; 310(15):1619-20. PubMed ID: 24129466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
    Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
    Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention.
    Hull MW; Wu Z; Montaner JS
    Curr Opin HIV AIDS; 2012 Nov; 7(6):579-86. PubMed ID: 23076123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postexposure prophylaxis for HIV following sexual exposure.
    Barber TJ; Benn PD
    Curr Opin HIV AIDS; 2010 Jul; 5(4):322-6. PubMed ID: 20543608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and Prevention of HIV Among Transgender Adults.
    Radix AE
    Top Antivir Med; 2020; 28(3):474-478. PubMed ID: 34107207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral Therapy for HIV Infection: When to Initiate Therapy, Which Regimen to Use, and How to Monitor Patients on Therapy.
    Johnson SC
    Top Antivir Med; 2016 Dec-2017 Jan; 23(5):161-7. PubMed ID: 27398769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of HIV-1 infection with antiretroviral therapy.
    Tao X; Shao D; Xue W
    N Engl J Med; 2011 Nov; 365(20):1934-5; author reply 1935. PubMed ID: 22087689
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of HIV-1 infection with antiretroviral therapy.
    Rodger A; Phillips A; Lundgren J
    N Engl J Med; 2011 Nov; 365(20):1934; author reply 1935. PubMed ID: 22087688
    [No Abstract]   [Full Text] [Related]  

  • 20. Achieving improvements across the HIV treatment cascade: a clinical management algorithm based on IAPAC's entry into and retention in care and antiretroviral therapy adherence guidelines.
    Zuniga JM; Young B
    J Int Assoc Provid AIDS Care; 2013; 12(1):15-7. PubMed ID: 23512144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.